12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Photofrin porfimer sodium: Phase I started

Researchers at Medical College of Wisconsin (MCW) and Children's Hospital of Wisconsin began an open-label, dose-escalation, U.S. Phase I trial to evaluate 0.5, 1.3, 2 and 3 mg/kg IV Photofrin 24 hours prior to PDT in about 24 patients ages...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >